Patents Cannot Be Blamed for Inequitable Access to COVID-19 Vaccines
Biotechnology Law Report
; 41(2):7, 2022.
Article
in English
| Web of Science | ID: covidwho-1819771
ABSTRACT
In view of the inequitable distribution of COVID-19 vaccines, several initiatives have been discussed to waive respective patent rights. This article provides a fact-based multinational study on patent rights protecting BioNTech-Pfizer's vaccine BNT162b2. We conclude that although there actually is a vaccine shortage in many countries, patents cannot be blamed as the scapegoat for said situation.
Full text:
Available
Collection:
Databases of international organizations
Database:
Web of Science
Topics:
Vaccines
Language:
English
Journal:
Biotechnology Law Report
Year:
2022
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS